2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates
and insights - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its
mortality is third among all solid tumors, behind carcinomas of the lung and the colon …

This guidance provides a data-supported approach to the diagnosis, staging, and treatment
of patients diagnosed with hepatocellular carcinoma (HCC). A guidance document is …

Hepatobiliary cancers which include hepatocellular carcinoma (HCC) and biliary tract
cancers (ie, cholangiocarcinoma and gallbladder carcinoma) are associated with significant …

It would be impossible to summarise all of the significant developments in the surgical
management of hepatocellular carcinoma (HCC), even just over the past year, in a …

Liver resection is one of the main curative options for early hepatocellular carcinoma (HCC)
in patients with cirrhosis and is the treatment of choice in non-cirrhotic patients. However …

Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver and has an
overall five-year survival rate of less than twenty percent. For patients with unresectable …

Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and
Future Directions. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

Background Curative liver resection is the treatment of choice for both primary and
secondary liver malignancies. However, an inadequate future liver remnant (FLR) frequently …

Purpose To compare the efficacy and safety of hepatic arterial infusion chemotherapy
(HAIC) to transarterial chemoembolization/embolization (TACE/TAE) for the treatment of …